Search research articles
Contact Us
Filters
Showing results (41-50 of 169) with videos related to
Page
of 17
Sort By:
British Journal of Haematology
|
February 14, 2002
CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia
Patrice Chevallier, Dominique Penther, Hervé Avet-Loiseau, et al.
Haematologica
|
December 17, 2009
Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody
Nicolas Chapuis, Jérôme Tamburini, Pascale Cornillet-Lefebvre, et al.
Oncoimmunology
|
September 14, 2016
The ecto-ATPDase CD39 is involved in the acquisition of the immunoregulatory phenotype by M-CSF-macrophages and ovarian cancer tumor-associated macrophages: Regulatory role of IL-27
Sènan M d'Almeida, Gilles Kauffenstein, Charlotte Roy, et al.
Blood Cancer Journal
|
May 26, 2018
Monitoring of asparagine depletion and anti-L-asparaginase antibodies in adult acute lymphoblastic leukemia treated in the pediatric-inspired GRAALL-2005 trial
Jérôme Paillassa, Thibaut Leguay, Xavier Thomas, et al.
Haematologica
|
December 7, 2007
Outcome of adult T-lymphoblastic lymphoma after acute lymphoblastic leukemia-type treatment: a GOELAMS trial
Mathilde Hunault, Malgorzata Truchan-Graczyk, Denis Caillot, et al.
Scientific Reports
|
October 21, 2016
Cytoplasmic proliferating cell nuclear antigen connects glycolysis and cell survival in acute myeloid leukemia
Delphine Ohayon, Alessia De Chiara, Nicolas Chapuis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2008
Long-term disease-free survival after gemtuzumab, intermediate-dose cytarabine, and mitoxantrone in patients with CD33(+) primary resistant or relapsed acute myeloid leukemia
Patrice Chevallier, Jacques Delaunay, Pascal Turlure, et al.
Haematologica
|
March 6, 2016
An early thymic precursor phenotype predicts outcome exclusively in HOXA-overexpressing adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study
Jonathan Bond, Tony Marchand, Aurore Touzart, et al.
Leukemia & Lymphoma
|
April 10, 2015
Unlike ASXL1 and ASXL2 mutations, ASXL3 mutations are rare events in acute myeloid leukemia with t(8;21)
Nicolas Duployez, Jean-Baptiste Micol, Nicolas Boissel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2010
Allogeneic stem-cell transplantation in patients with Waldenström macroglobulinemia: report from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
Charalampia Kyriakou, Carmen Canals, Jan J Cornelissen, et al.
Page
of 17
Search research articles
Search
Showing results (41-50 of 169) with videos related to
Sort By:
Page
of 17
British Journal of Haematology
|
February 14, 2002
CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia
Patrice Chevallier, Dominique Penther, Hervé Avet-Loiseau, et al.
Haematologica
|
December 17, 2009
Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody
Nicolas Chapuis, Jérôme Tamburini, Pascale Cornillet-Lefebvre, et al.
Oncoimmunology
|
September 14, 2016
The ecto-ATPDase CD39 is involved in the acquisition of the immunoregulatory phenotype by M-CSF-macrophages and ovarian cancer tumor-associated macrophages: Regulatory role of IL-27
Sènan M d'Almeida, Gilles Kauffenstein, Charlotte Roy, et al.
Blood Cancer Journal
|
May 26, 2018
Monitoring of asparagine depletion and anti-L-asparaginase antibodies in adult acute lymphoblastic leukemia treated in the pediatric-inspired GRAALL-2005 trial
Jérôme Paillassa, Thibaut Leguay, Xavier Thomas, et al.
Haematologica
|
December 7, 2007
Outcome of adult T-lymphoblastic lymphoma after acute lymphoblastic leukemia-type treatment: a GOELAMS trial
Mathilde Hunault, Malgorzata Truchan-Graczyk, Denis Caillot, et al.
Scientific Reports
|
October 21, 2016
Cytoplasmic proliferating cell nuclear antigen connects glycolysis and cell survival in acute myeloid leukemia
Delphine Ohayon, Alessia De Chiara, Nicolas Chapuis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2008
Long-term disease-free survival after gemtuzumab, intermediate-dose cytarabine, and mitoxantrone in patients with CD33(+) primary resistant or relapsed acute myeloid leukemia
Patrice Chevallier, Jacques Delaunay, Pascal Turlure, et al.
Haematologica
|
March 6, 2016
An early thymic precursor phenotype predicts outcome exclusively in HOXA-overexpressing adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study
Jonathan Bond, Tony Marchand, Aurore Touzart, et al.
Leukemia & Lymphoma
|
April 10, 2015
Unlike ASXL1 and ASXL2 mutations, ASXL3 mutations are rare events in acute myeloid leukemia with t(8;21)
Nicolas Duployez, Jean-Baptiste Micol, Nicolas Boissel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2010
Allogeneic stem-cell transplantation in patients with Waldenström macroglobulinemia: report from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
Charalampia Kyriakou, Carmen Canals, Jan J Cornelissen, et al.
Page
of 17